Two weeks ago, KKR's ambulance firm was pitching a $5 billion IPO. Today it's pitching $3.3 billion.
The share count did not change. The price the market would pay did.
GMR Solutions is based in Lewisville, Texas. It runs air and ground ambulances under the Global Medical Response name.
KKR has backed the firm for years. The first plan was 31.9 million shares at $22 to $25 each.
That would have raised up to $797.9 million.
The new plan: the same 31.9 million shares at $15. That gets the firm to about $478.7 million.
The valuation cap dropped from about $5 billion to roughly $3.3 billion. That is a 34% cut on what KKR could have walked away with.
It's the kind of repricing that says investors have stopped paying up for private equity exits at any price.
We break down what deals like this mean for your money in Market Briefs. Five minutes a day, with a free investing masterclass on top.
IPO buyers have been pickier all year. The Iran war added a price shock that pushed back the Fed's cut path.
When rates stay high for longer, the math on growth IPOs gets tighter.
GMR is the cleanest read on demand this week. The bankers could not fill the deal at the first range.
The choice was a haircut now or a busted IPO later.
Plenty of private equity owners are watching. The playbook used to be: hold, file, exit at a healthy price.
GMR just showed that the public market gets the final word on what "healthy" means.
KKR isn't the only firm dealing with this. Sponsors across the IPO calendar have either trimmed deals or pulled them.
Some have taken longer paths. Sponsors are doing more dividend recaps, private placements, and stock pledges.
Going public used to be the cleanest exit. Right now it isn't.
For investors, the GMR price says something about real value. At $3.3 billion, the firm trades near 8 times last year's earnings. At $5 billion, it would have traded near 12 times.
That's a big gap. Public buyers wanted the lower number, and the Iran war plus sticky prices made them right.
The stock trades Wednesday on the NYSE under the ticker GMRS. The first-day trade is the real test of whether $15 holds.
If it slips, the next PE-backed filings will likely price even cheaper.
Watch the IPO calendar for the rest of May. Pulled deals or fresh markdowns would say the demand issue is widening.
Also watch KKR's stock. Its quarterly results lean on big exits like this one to drive returns.
Healthcare names have had a mixed year on the public market. Hospital chains and ambulance firms face wage hikes and rate pressure at once.
Watch how GMR opens against its 2024 peers. A green debut would suggest the cut got the price right, while a weak debut would mean even $15 was too high.
The IPO window isn't closed. It's just a lot less forgiving than KKR thought.
Want this kind of read on the market each weekday? Sign up for Market Briefs and a free 45-minute investing course is part of the package.
